Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

NCT06765161 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Myasthaenia Gravis

Interventions

DRUG: efgartigimod administration

Sponsor

Clinique Neuro-Outaouais

Collaborators

[object Object]